CTOs on the Move


 
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serves customers in over 175 countries. Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion
  • www.idexx.com
  • One IDEXX Drive
    Westbrook, ME USA 04092
  • Phone: 207.856.0300

Executives

Name Title Contact Details
Ken Grady
Corporate Vice President and Chief Information Officer Profile
Christopher Thompson
Director of Information Technology, Global Commercial Technology Profile

Jobs

Deputy Chief Information Security Officer

Idexx Westbrook, ME
Details here:
https://careers.idexx.com/us/en/job/J-048734/Deputy-Chief-Information-Security-Officer-Deputy-CISO?utm_source=indeed&utm_medium=phenom-feeds&source=indeed&utm_medium=ppc

Similar Companies

Unilab Corp

Unilab Corp is a Fullerton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Uhrich Michael

Uhrich Michael is a Euclid, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Agendia USA

Agendia is a precision oncology company headquartered in Irvine, California, committed to bringing patients with early stage breast cancer and their physicians the information they need to make the best decisions for the full treatment journey. The company currently offers two commercially-available genomic profiling tests, supported by the highest levels of clinical and real world evidence, that provide comprehensive genomic information that can be used to identify the most effective breast cancer treatment possible for each patient. MammaPrint®, the 70-gene breast cancer recurrence assay, is the only FDA-cleared risk of recurrence test backed by peer-reviewed, prospective outcome data and inclusion in both national and international treatment guidelines. BluePrint®, the 80-gene molecular subtyping assay, is the only commercially-available test that evaluates the underlying biology of a tumor to determine what is driving its growth. Together, MammaPrint® and BluePrint® provide a comprehensive genomic profile to help physicians make more informed decisions in the pre- and post-operative treatment settings. Agendia develops evidence-based novel genomic tests and forges partnerships with groundbreaking companies to develop next-generation digital treatment tools. The ongoing research builds an arsenal of data that improve patient outcomes and support the evolving clinical needs of patients with breast cancer and their physicians every step of the way, from initial diagnosis to cancer-free.

Digital Medical Systems

Digital Medical Systems is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dekalb County Board of Health

Dekalb County Board of Health is a Decatur, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.